Is hyperprogressive disease a specific phenomenom of immunotherapy?

• Main Authors: Marta Brambilla (Author), Giuseppe Lo Russo (Author), Roberto Ferrara (Author), Sara Manglaviti (Author), Marina Chiara Garassino (Author), Mario Occhipinti (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a...